Selectivity problems with drugs acting on cardiac Na+ and Ca2+ channels

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

With the increase of our knowledge on cardioactive agents it comes more and more clear that practically none of the currently used compounds shows absolute selectivity to one or anotherion channel type. This is particularly true for Na+ and Ca2+ channel modulators, which are widely applied in the clinical practice and biomedical research. The best example might be probably the marine guanidine poison tetrodotoxin, which has long been considered as a selective Na+ channel blocker, while recently it turned out to effectively inhibit cardiac Ca2+ currents as well. In the present study the cross actions observed between the effects of various blockers of Na+ channels (such as toxin inhibitors, class I antiarrhythmics and local anesthetics) and Ca2+ channels (like phenylalkylamines, dihydropyridine compounds, diltiazem and mibefradil) are overviewed in light of the known details of the respective channel structures. Similarly, activators of Na+ channels, including veratridine and batrachotoxin, are also compared. The binding of tetrodotoxin and saxitoxin to Cav1.2 and Nav1.5 channel proteins is presented by construction of theoretical models to reveal common structures in their pore forming regions to explain cross reactions. Since these four domain channels can be traced back to a common ancestor, a close similarity in their structure can well be demonstrated. Thus, the poor selectivity of agents acting on cardiac Na+ and Ca 2+ channels is a consequence of evolution. As a conclusion, since the limited selectivity is an intrinsic property of drug receptors, it has to be taken into account when designing new cardioactive compounds for either medical therapy or experimental research in the future.

Original languageEnglish
Pages (from-to)2552-2571
Number of pages20
JournalCurrent Medicinal Chemistry
Volume20
Issue number20
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Tetrodotoxin
Batrachotoxins
Mibefradil
Saxitoxin
Veratridine
Drug Receptors
Investigational Therapies
Diltiazem
Poisons
Guanidine
Cross Reactions
Local Anesthetics
Pharmaceutical Preparations
Modulators
Biomedical Research
Theoretical Models
Research
Proteins
1,4-dihydropyridine

Keywords

  • Ca channels
  • Cardioactive drugs
  • Channel structures
  • Ion selectivity
  • Na channels
  • Tetrodotoxin

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Selectivity problems with drugs acting on cardiac Na+ and Ca2+ channels. / Hegyi, Bence; Komáromi, I.; Nánási, P.; Szentandrássy, N.

In: Current Medicinal Chemistry, Vol. 20, No. 20, 07.2013, p. 2552-2571.

Research output: Contribution to journalArticle

@article{d93a31207e15401a8b8f194399e9fb40,
title = "Selectivity problems with drugs acting on cardiac Na+ and Ca2+ channels",
abstract = "With the increase of our knowledge on cardioactive agents it comes more and more clear that practically none of the currently used compounds shows absolute selectivity to one or anotherion channel type. This is particularly true for Na+ and Ca2+ channel modulators, which are widely applied in the clinical practice and biomedical research. The best example might be probably the marine guanidine poison tetrodotoxin, which has long been considered as a selective Na+ channel blocker, while recently it turned out to effectively inhibit cardiac Ca2+ currents as well. In the present study the cross actions observed between the effects of various blockers of Na+ channels (such as toxin inhibitors, class I antiarrhythmics and local anesthetics) and Ca2+ channels (like phenylalkylamines, dihydropyridine compounds, diltiazem and mibefradil) are overviewed in light of the known details of the respective channel structures. Similarly, activators of Na+ channels, including veratridine and batrachotoxin, are also compared. The binding of tetrodotoxin and saxitoxin to Cav1.2 and Nav1.5 channel proteins is presented by construction of theoretical models to reveal common structures in their pore forming regions to explain cross reactions. Since these four domain channels can be traced back to a common ancestor, a close similarity in their structure can well be demonstrated. Thus, the poor selectivity of agents acting on cardiac Na+ and Ca 2+ channels is a consequence of evolution. As a conclusion, since the limited selectivity is an intrinsic property of drug receptors, it has to be taken into account when designing new cardioactive compounds for either medical therapy or experimental research in the future.",
keywords = "Ca channels, Cardioactive drugs, Channel structures, Ion selectivity, Na channels, Tetrodotoxin",
author = "Bence Hegyi and I. Kom{\'a}romi and P. N{\'a}n{\'a}si and N. Szentandr{\'a}ssy",
year = "2013",
month = "7",
doi = "10.2174/09298673113209990123",
language = "English",
volume = "20",
pages = "2552--2571",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "20",

}

TY - JOUR

T1 - Selectivity problems with drugs acting on cardiac Na+ and Ca2+ channels

AU - Hegyi, Bence

AU - Komáromi, I.

AU - Nánási, P.

AU - Szentandrássy, N.

PY - 2013/7

Y1 - 2013/7

N2 - With the increase of our knowledge on cardioactive agents it comes more and more clear that practically none of the currently used compounds shows absolute selectivity to one or anotherion channel type. This is particularly true for Na+ and Ca2+ channel modulators, which are widely applied in the clinical practice and biomedical research. The best example might be probably the marine guanidine poison tetrodotoxin, which has long been considered as a selective Na+ channel blocker, while recently it turned out to effectively inhibit cardiac Ca2+ currents as well. In the present study the cross actions observed between the effects of various blockers of Na+ channels (such as toxin inhibitors, class I antiarrhythmics and local anesthetics) and Ca2+ channels (like phenylalkylamines, dihydropyridine compounds, diltiazem and mibefradil) are overviewed in light of the known details of the respective channel structures. Similarly, activators of Na+ channels, including veratridine and batrachotoxin, are also compared. The binding of tetrodotoxin and saxitoxin to Cav1.2 and Nav1.5 channel proteins is presented by construction of theoretical models to reveal common structures in their pore forming regions to explain cross reactions. Since these four domain channels can be traced back to a common ancestor, a close similarity in their structure can well be demonstrated. Thus, the poor selectivity of agents acting on cardiac Na+ and Ca 2+ channels is a consequence of evolution. As a conclusion, since the limited selectivity is an intrinsic property of drug receptors, it has to be taken into account when designing new cardioactive compounds for either medical therapy or experimental research in the future.

AB - With the increase of our knowledge on cardioactive agents it comes more and more clear that practically none of the currently used compounds shows absolute selectivity to one or anotherion channel type. This is particularly true for Na+ and Ca2+ channel modulators, which are widely applied in the clinical practice and biomedical research. The best example might be probably the marine guanidine poison tetrodotoxin, which has long been considered as a selective Na+ channel blocker, while recently it turned out to effectively inhibit cardiac Ca2+ currents as well. In the present study the cross actions observed between the effects of various blockers of Na+ channels (such as toxin inhibitors, class I antiarrhythmics and local anesthetics) and Ca2+ channels (like phenylalkylamines, dihydropyridine compounds, diltiazem and mibefradil) are overviewed in light of the known details of the respective channel structures. Similarly, activators of Na+ channels, including veratridine and batrachotoxin, are also compared. The binding of tetrodotoxin and saxitoxin to Cav1.2 and Nav1.5 channel proteins is presented by construction of theoretical models to reveal common structures in their pore forming regions to explain cross reactions. Since these four domain channels can be traced back to a common ancestor, a close similarity in their structure can well be demonstrated. Thus, the poor selectivity of agents acting on cardiac Na+ and Ca 2+ channels is a consequence of evolution. As a conclusion, since the limited selectivity is an intrinsic property of drug receptors, it has to be taken into account when designing new cardioactive compounds for either medical therapy or experimental research in the future.

KW - Ca channels

KW - Cardioactive drugs

KW - Channel structures

KW - Ion selectivity

KW - Na channels

KW - Tetrodotoxin

UR - http://www.scopus.com/inward/record.url?scp=84877966577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877966577&partnerID=8YFLogxK

U2 - 10.2174/09298673113209990123

DO - 10.2174/09298673113209990123

M3 - Article

VL - 20

SP - 2552

EP - 2571

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 20

ER -